Primary Site >> Colorectal Cancer

Gene >> CXCL5

Journal: Int J Oncol. 2007 Jul;31(1):97-102.
Title: Expression and gene polymorphisms of the chemokine CXCL5 in colorectal cancer patients.
Author: Dimberg, Jan|Dienus, Olaf|Lofgren, Sture|Hugander, Anders|Wagsater, Dick
PMID: 17549409
Journal: Clin Cancer Res. 2008 Apr 15;14(8):2276-84.
Title: Disrupted expression of CXCL5 in colorectal cancer is associated with rapid tumor formation in rats and poor prognosis in patients.
Author: Speetjens, Frank M|Kuppen, Peter J K|Sandel, Maro H|Menon, Anand G|Burg, Danny|van de Velde, Cornelis J H|Tollenaar, Rob A E M|de Bont, Hans J G M|Nagelkerke, J Fred
PMID: 18413816
Journal: BMC Cancer. 2008 Jun 25;8:178.
Title: ELR+ CXC chemokine expression in benign and malignant colorectal conditions.
Author: Rubie, Claudia|Frick, Vilma Oliveira|Wagner, Mathias|Schuld, Jochen|Graber, Stefan|Brittner, Brigitte|Bohle, Rainer M|Schilling, Martin K
PMID: 18578857
Journal: PLoS One. 2009;4(2):e4388.
Title: Five quantitative trait loci control radiation-induced adenoma multiplicity in Mom1R Apc Min/+ mice.
Author: Elahi, Eiram|Suraweera, Nirosha|Volikos, Emmanouil|Haines, Jackie|Brown, Natalie|Davidson, Gerovie|Churchman, Mike|Ilyas, Mohammed|Tomlinson, Ian|Silver, Andrew
PMID: 19194513
Journal: PLoS One. 2011;6(11):e27944.
Title: Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.
Author: Michielsen, Adriana J|Hogan, Andrew E|Marry, Joseph|Tosetto, Miriam|Cox, Fionnuala|Hyland, John M|Sheahan, Kieran D|O'Donoghue, Diarmuid P|Mulcahy, Hugh E|Ryan, Elizabeth J|O'Sullivan, Jacintha N
PMID: 22125641
Journal: J Pediatr Gastroenterol Nutr. 2012 Mar;54(3):414-21.
Title: Neutrophil transintestinal epithelial migration to CXCR2 ligands is regulated by adenosine.
Author: Stadnyk, Andrew W|Carrigan, Svetlana O|Otley, Anthony R
PMID: 21857250
Journal: Eur J Cancer. 2012 Sep;48(14):2244-51.
Title: CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Author: Kawamura, Mikio|Toiyama, Yuji|Tanaka, Kouji|Saigusa, Susumu|Okugawa, Yoshinaga|Hiro, Junichiro|Uchida, Keiichi|Mohri, Yasuhiko|Inoue, Yasuhiro|Kusunoki, Masato
PMID: 22197219
Journal: Oncoimmunology. 2015 Jan 22;4(9):e1002721.
Title: IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity.
Author: Bahri, Rajia|Pateras, Ioannis S|D'Orlando, Orietta|Goyeneche-Patino, Diego A|Campbell, Michelle|Polansky, Julia K|Sandig, Hilary|Papaioannou, Marilena|Evangelou, Kostas|Foukas, Periklis G|Gorgoulis, Vassilis G|Bulfone-Paus, Silvia
PMID: 26405589
Journal: Comput Biol Chem. 2015 Dec;59 Pt B:15-31.
Title: Network regularised Cox regression and multiplex network models to predict disease comorbidities and survival of cancer.
Author: Xu, Haoming|Moni, Mohammad Ali|Lio, Pietro
PMID: 26611766
Journal: Oncogene. 2016 May 19;35(20):2634-44.
Title: Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling.
Author: Sanchez-Lopez, E|Flashner-Abramson, E|Shalapour, S|Zhong, Z|Taniguchi, K|Levitzki, A|Karin, M
PMID: 26364612
Journal: Mol Cancer. 2017 Mar 29;16(1):70.
Title: Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3beta/beta-catenin pathways.
Author: Zhao, Jingkun|Ou, Baochi|Han, Dingpei|Wang, Puxiongzhi|Zong, Yaping|Zhu, Congcong|Liu, Di|Zheng, Minhua|Sun, Jing|Feng, Hao|Lu, Aiguo
PMID: 28356111
Journal: Oncotarget. 2017 Apr 25;8(17):28442-28454.
Title: Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer.
Author: Zhao, Jingkun|Ou, Baochi|Feng, Hao|Wang, Puxiongzhi|Yin, Shuai|Zhu, Congcong|Wang, Shenjie|Chen, Chun|Zheng, Minhua|Zong, Yaping|Sun, Jing|Lu, Aiguo
PMID: 28415702
Journal: J Clin Invest. 2017 Aug 1;127(8):3039-3051.
Title: Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.
Author: Jung, Keehoon|Heishi, Takahiro|Khan, Omar F|Kowalski, Piotr S|Incio, Joao|Rahbari, Nuh N|Chung, Euiheon|Clark, Jeffrey W|Willett, Christopher G|Luster, Andrew D|Yun, Seok Hyun|Langer, Robert|Anderson, Daniel G|Padera, Timothy P|Jain, Rakesh K|Fukumura, Da
PMID: 28691930
Journal: Biosens Bioelectron. 2018 Feb 15;100:396-403.
Title: Development of a bifunctional nanobiosensor for screening and detection of chemokine ligand in colorectal cancer cell line.
Author: Chung, Saeromi|Chandra, Pranjal|Koo, Jaseok Peter|Shim, Yoon-Bo
PMID: 28954256
Journal: Cancer Cell Int. 2018 May 2;18:68.
Title: Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis.
Author: Hu, Binwu|Fan, Huiqian|Lv, Xiao|Chen, Songfeng|Shao, Zengwu
PMID: 29743818
Journal: Oncotarget. 2018 Jun 19;9(47):28445-28455.
Title: Silencing NIK potentiates anti-VEGF therapy in a novel 3D model of colorectal cancer angiogenesis.
Author: Maracle, Chrissta X|Jeucken, Kim C M|Helder, Boy|van Gulik, Thomas M|Steins, Anne|van Laarhoven, Hanneke W M|Tas, Sander W
PMID: 29983872
Journal: Oncogene. 2018 Sep 10. pii: 10.1038/s41388-018-0492-9.
Title: Loss of solute carrier family 7 member 2 exacerbates inflammation-associated colon tumorigenesis.
Author: Coburn, Lori A|Singh, Kshipra|Asim, Mohammad|Barry, Daniel P|Allaman, Margaret M|Al-Greene, Nicole T|Hardbower, Dana M|Polosukhina, Dina|Williams, Christopher S|Delgado, Alberto G|Piazuelo, M Blanca|Washington, M Kay|Gobert, Alain P|Wilson, Keith T
PMID: 30202097
Journal: Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2481-2484.
Title: Clinical Value of CXCL5 for Determining of Colorectal Cancer
Author: Yildirim, Kadir|Colak, Elif|Aktimur, Recep|Gun, Seda|Taskin, Mehmet Hakan|Nigdelioglu, Adil|Aktimur, Sude Hatun|Karagoz, Filiz|Ozlem, Nuraydin
PMID: 30255816